Fuwei Films Reschedules Reporting of Its Financial Results for the Second Quarter of 2022
Fuwei Films (Nasdaq: FFHL) announced a delay in reporting its financial results for the Second Quarter of 2022, now scheduled for September 29, 2022. The company, a leading manufacturer of BOPET plastic films in China, operates through its wholly-owned subsidiary, Fuwei Films (Shandong). The delay comes amid various risk factors including potential trading prohibitions under the Holding Foreign Companies Accountable Act, uncertainties in the global market, and challenges in the BOPET film industry.
- None.
- Delay in financial results reporting could affect investor confidence.
- Risks associated with potential trading prohibitions in the US under the Holding Foreign Companies Accountable Act.
- Oversupply of BOPET films due to rapid industry capacity growth could impact pricing.
- Uncertainty related to changes in the international market, trade barriers, and anti-dumping duties.
- Operational risks related to COVID-19 and its effect on business continuity.
BEIJING, Aug. 30, 2022 /PRNewswire/ -- Fuwei Films (Holdings) Co., Ltd. (Nasdaq: FFHL) ("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET plastic films in China, today announced that the reporting of its financial results for the Second Quarter of 2022 is delayed to September 29, 2022.
About Fuwei Films
Fuwei Films conducts its business through its wholly-owned subsidiary, Fuwei Films (Shandong) Co., Ltd. ("Shandong Fuwei"). Shandong Fuwei develops, manufactures, and distributes high-quality plastic films using the biaxial oriented stretch technique, otherwise known as BOPET film (biaxially oriented polyethylene terephthalate). Fuwei's BOPET film is widely used for packaging food, medicine, cosmetics, tobacco, and alcohol, as well as in the imaging, electronics, and magnetic products industries.
Safe Harbor
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is subject to risks. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission which, among other things, include negative impacts of the determination of the U.S. Securities and Exchange Commission that the Public Company Accounting Oversight Board ("PCAOB") is currently unable to inspect our auditor in relation to their audit work and the potential that our ordinary shares will be prohibited from trading in the United States under the Holding Foreign Companies Accountable Act ("HFCAA") in 2024 if the PCAOB is unable to inspect or fully investigate auditors located in China, or 2023 if proposed changes to the law are enacted, the significant oversupply of BOPET films resulting from the rapid growth of the Chinese BOPET industry capacity, changes in the international market and trade barriers, especially the uncertainty of the antidumping investigation and imposition of an anti-dumping duty on imports of the BOPET films originating from the People's Republic of China ("China") conducted by certain countries; uncertainty around coronavirus (COVID-19) outbreak and the effects of government and other measures seeking to contain its spread, potential delisting of our ordinary shares under the Holding Foreign Company Affordable Act if the US Public Company Accounting Oversight Board is unable to inspect our auditors located in China, uncertainty around U.S.-China trade war and its effect on the Company's operation, fluctuations of the RMB exchange rate, and our ability to obtain adequate financing for our planned capital expenditure requirements; uncertainty as to our ability to continuously develop new BOPET film products and keep up with changes in BOPET film technology; risks associated with possible defects and errors in our products; uncertainty as to our ability to protect and enforce our intellectual property rights; uncertainty as to our ability to attract and retain qualified executives and personnel; and uncertainty in acquiring raw materials on time and on acceptable terms, particularly in view of the volatility in the prices of petroleum products in recent years. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release. Actual results of our operations may differ materially from the information contained in the forward-looking statements as a result of the risk factors.
View original content:https://www.prnewswire.com/news-releases/fuwei-films-reschedules-reporting-of-its-financial-results-for-the-second-quarter-of-2022-301614868.html
SOURCE Fuwei Films
FAQ
When will Fuwei Films report its financial results for Q2 2022?
What is the stock symbol for Fuwei Films?
What are the risks mentioned in Fuwei Films' press release?
Why was the financial results report for Fuwei Films delayed?
